NEOMED Library: Journal Club Presentation Resources (Statistics Help): Confounders / Placebo Control or Other Control

Confounders

Bias, Confounding and Effect Modification
Dr. Eugene Lengerich - Penn State University Eberly College of Science
Clinical Trial Design Issues: At Least 10 Things You Should Look for in Clinical Trials
Glasser SP, Howard G. Clinical trial design issues: at least 10 things you should look for in clinical trials. J Clin Pharmacol. 2006;46(10):1106-15.
Confounding
epiCentral University of Michigan School of Public Health - Office of Public Health Practice
Confounding in Observational Studies Explained
What is a Confounding Factor?
California Department of Public Health
Association or Causation? How Do We Ever Know?
CEBM and University of Oxford's Catalogue of Bias. It includes an explanation of confounding.

Placebo Control or Active Control

Clinical Trial Design Issues: At Least 10 Things You Should Look for in Clinical Trials
Glasser SP, Howard G. Clinical trial design issues: at least 10 things you should look for in clinical trials. J Clin Pharmacol. 2006;46(10):1106-15.
Drug Study Designs - Information Sheet Guidance for Institutional Review Boards and Clinical Investigators
U.S. Food and Drug Administration
Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues
Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med. 2000;133(6):455-63.
Placebo-controlled Trials and Active-control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases
Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med. 2000;133(6):464-70.
Placebo Versus Best-Available-Therapy Control Group in Clinical Trials for Pharmacologic Therapies Which Is Better?
Castro M. Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies.Proc Am Thorac Soc. 2007 Oct 1;4(7):570-3.
Sham Procedure Versus Usual Care as the Control in Clinical Trials of Devices: Which is Better?
Sutherland ER. Sham procedure versus usual care as the control in clinical trials of devices: which is better?. Proc Am Thorac Soc. 2007;4(7):574-6.

COLLECTIONS BY FORMAT:

KEY RESOURCES:

SERVICES:

SPACES:

Journal Club Presentation Resources (Statistics Help): Confounders / Placebo Control or Other Control

Confounders

Placebo Control or Active Control